- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04262505
A MEDiterranean Diet in Rheumatoid Arthritis
May 16, 2022 updated by: Tala Raad, University of Limerick
A MEDiterranean Diet in Rheumatoid Arthritis (MEDRA)
The MEDRA study is a 12-week randomised controlled trial that aims to assess effects of a Mediterranean dietary telehealth intervention compared to the Irish Healthy Eating guidelines on the physical function and quality of life of adults living with Rheumatoid Arthritis in Ireland.
Investigators will be able to determine how closely people living in Ireland can accept the Mediterranean dietary practices and adhere to them with dietetic input and guidance.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Rheumatoid arthritis (RA) is a long-term inflammatory disease which commonly occurs in the small joints of the hands, wrists and feet leading to swelling, pain and stiffness in the affected joints.
The condition is two to three times more prevalent in women than in men.
Although it might occur at any age, the incidence of the disease is highest between the ages of 40 and 65 years.
Currently, there is no treatment that provides complete remission of the disease for people living with RA.
Treatment of RA aims to reduce the symptoms and improve the health of the patient.
Although diet is not part of the mainstream treatment, many studies have reported beneficial effects of certain diets on RA symptoms.
The MEDRA study will examine the habitual dietary intakes of people living with RA in Ireland and will explore whether people with RA will benefit from either a Mediterranean dietary pattern or the Healthy eating guidelines in Ireland.
This small scale study will provide useful information on whether people with RA in Ireland can adhere to a Mediterranean dietary pattern and whether the intervention will have beneficial impact on the physical function and quality of life.
This is important work prior to proceeding to larger intervention studies.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Limerick, Ireland, V94 F858
- University Hospital Limerick
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 18 year
- Definite diagnosis of rheumatoid arthritis according to ACR or EULAR criteria
- Full access to Internet/smartphone
- English speaking
Exclusion Criteria:
- Age <18 years
- Breastfeeding, pregnant or trying to get pregnant.
- Patients who have commenced nutritional supplements or a new dietary regime in the month prior to study enrolment.
- Patients who do not have access to the Internet/smartphone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mediterranean Diet Group (Group A)
The intervention is based on components of the traditional Mediterranean diet which is primarily a plant based diet and emphasises intakes of vegetables, whole grains and fruit with the main added fat being extra virgin olive oil.The diet will be modified and tailored to cultured preferences by the registered dietitian.
Participants will be informed of their diet allocation group during the baseline teleconsultation and will commence the diet the following day or as soon as is feasible for 12 weeks.
Participants will be provided with resources specifically designed to explain the components of the Mediterranean diet and how it will be followed.
|
Participants will be advised to follow a traditional Mediterranean diet
|
Experimental: Healthy Eating Group (Group B)
Participants assigned to the Healthy Eating group will be advised to adhere to the current healthy eating guidelines and will be provided with resources to inform them of these guidelines and sample meal plans that are readily available on the Healthy Ireland website.
|
Participants will be advised to follow the Healthy Eating Guidelines in Ireland
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Quality of Life
Time Frame: Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
Rheumatoid Arthritis Quality of Life questionnaire (RAQoL) will be used to describe the individuals' perceptions, satisfaction, and evaluation of different areas of their own lives, such as physical health and functioning, psychological and emotional well-being, social roles, and relationships.
A scale 1 to 30 will be used whereby the higher the score, the worse the QoL.
|
Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
Changes in Physical Function
Time Frame: Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
The health assessment questionnaire disability index (HAQ-DI) is an index used to assess how arthritis impacts the participant's everyday life.
A scale 0-3 is used whereby 3 indicated very severe disability.
|
Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Diet adherence
Time Frame: Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
Assessment of participants' adherence to either the Mediterranean diet or the current Irish Healthy Guidelines will be assessed using a PREDIMED validated checklist and a Healthy Eating checklist respectively.
Higher scores indicate greater adherence to the diet assigned.
A 3-day food diary will also be used to captures the dietary intake of participants
|
Throughout the 12 weeks study period (At baseline, mid-intervention and post-intervention)
|
Change in Physical activity levels
Time Frame: Throughout the 12 week study period (At baseline, mid-intervention and post-intervention)
|
Assessment of participants' physical activity levels using the YPAS (Yale Physical activity survey)
|
Throughout the 12 week study period (At baseline, mid-intervention and post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Audrey Tierney, Unievrsity of Limerick
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 6, 2020
Primary Completion (Actual)
October 6, 2021
Study Completion (Actual)
October 6, 2021
Study Registration Dates
First Submitted
February 4, 2020
First Submitted That Met QC Criteria
February 5, 2020
First Posted (Actual)
February 10, 2020
Study Record Updates
Last Update Posted (Actual)
May 17, 2022
Last Update Submitted That Met QC Criteria
May 16, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEDRA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
Clinical Trials on Mediterranean Diet Group
-
University of CreteCompletedObstructive Sleep Apnoea | Hypopnoea SyndromeGreece
-
Clinica Alemana de SantiagoComisión Nacional de Investigación Científica y TecnológicaCompletedStroke, Ischemic | Stroke, AcuteChile
-
Washington University School of MedicineCompletedHypertension | Overweight | Glucose Intolerance | Hypercholesterolemia | Pre-hypertensionUnited States
-
University of ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileTerminatedMetabolic SyndromeChile
-
Purdue UniversityMushroom CouncilCompleted
-
Hippocration General HospitalCompleted
-
University of East AngliaNewcastle UniversityRecruitingDepression, AnxietyUnited Kingdom
-
University of California, IrvineCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Disorder | Myeloproliferative SyndromeUnited States
-
Gangnam Severance HospitalUnknown
-
Federico II UniversityCompletedMediterranean Diet | Neuroendocrine Tumours (NETs)Italy